Showing 6151-6160 of 8782 results for "".
- Quinnova Pharmaceuticals Announces the Launch of Ecoza Foamhttps://practicaldermatology.com/news/20140319-quinnova_pharmaceuticals_announces_the_launch_of_ecoza_foam/2459310/Quinnova Pharmaceuticals LLC, an affiliate of Exeltis, launched its recently FDA-approved Ecoza (econazole nitrate) topical foam 1%. Ecoza Foma is indicated for the treatment of inter
- Pierre Fabre Obtains FDA Approval to Market Hemangeol for the Treatment of Infantile Hemangiomahttps://practicaldermatology.com/news/20140319-pierre_fabre_obtains_fda_approval_to_market_hemangeol_for_the_treatment_of_infantile_hemangioma/2459311/Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for “proliferating infantile hemangioma requiring s
- Ferndale Healthcare Announces Partnership with Colon Cancer Alliancehttps://practicaldermatology.com/news/20140318-ferndale_healthcare_announces_partnership_with_colon_cancer_awareness/2459313/Ferndale Healthcare's RectiCare® Cream, intended to resolve all discomfort from rectal and anal conditions such as hemorrhoids and anal fissures, urges colon screening for cancer before individuals reach for their brand. The brand wants to promote individuals to not rush to treat when bleeding an
- Valeant Pharmaceuticals Donates $250,000 to The National Coalition Against Domestic Violencehttps://practicaldermatology.com/news/20140317-valeant_pharmaceuticals_donates_250000_to_the_national_coalition_against_domestic_violence/2459314/Valeant Pharmaceuticals North America, LLC donated $250,000 to the National Coalition Again
- Phase I Trial of Nivolumab Shows Long-Term Efficacy Against Melanomahttps://practicaldermatology.com/news/20140313-phase_i_trial_of_nivolumab_shows_long-term_efficacy_against_melanoma/2459318/A recent study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions, published online in the Journal of Clinical Oncology, provides the longest-term look so far at how melanom
- Deepak Chadha is New Vice President of Regulatory Affairs for Suneva Medicalhttps://practicaldermatology.com/news/20140311-deepak_chadha_is_new_vicepresident_of_regulatory_affairs_for_suneva_medical/2459319/Suneva Medical appointed Deepak Chadha to Vice President of Regulatory Affairs. Chadha's role will be leading the development and implantation of regulatory practices. Chairman and Chief Executive Officer, Nicholas L. Teti, Jr. said, “Deepak has been responsible for several global regula
- Antares Pharma Announces LEO Pharma's Launch of Otrexup (Methotrexate) Injection for Adults with Psoriasishttps://practicaldermatology.com/news/20140311-antares_pharma_announces_leo_pharmas_launch_of_otrexup_methotrexate_injection_for_adults_with_psoriasis/2459320/Antares Pharma, Inc. announced LEO Pharma's launch of Otrexup, the first FDA-approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector. "We are very pleased that
- Upcoming Events to Educate PAs and NPs about Psoriasishttps://practicaldermatology.com/news/20140310-upcoming_events_to_educate_pas_and_nps_about_psoriasis/2459321/Nurse practitioners and physician assistants aiming to deepen their understanding of psoriasis can attend upcoming events sponsored by the The National Psoriasis Foundation. The Nurse Practitioner Psoriasis Symposium, a joint symposium from the
- Aquavit Pharmaceuticals Appoints David J. Goldberg as Chief Medical Officerhttps://practicaldermatology.com/news/20140305-aquavit_pharmaceuticals_appoints_david_j_goldberg_as_chief_medical_officer/2459324/Aquavit Pharmaceuticals, Inc., appointed David J. Goldberg, MD, JD as its Chief Medical Officer. Dr. Goldberg is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and facial rejuvenation techniques. Prior to joining Aquavit,
- Robert T. Kelley of Caliber Imaging & Diagnostics Named Vice President of US Saleshttps://practicaldermatology.com/news/20140305-robert_t_kelley_of_caliber_imaging__diagnostics_named_vice_president_of_us_sales/2459325/Caliber Imaging and Diagnostics has declared Robert T. Kelley vice president of US sales. Kelley, originally director of clinical sales since 2011, was due for a promotion. "We are delighted to promote Bob to Vice President of Sales, just as we were truly fortunate when he agreed to join